Jen Milau Jennifer Milau

Back in July of 2017, Jen and her mother Cindy were working out, when Jen suddenly had difficulty breathing. Due to the nature of this issue, Cindy brought Jen to the emergency department, where she subsequently underwent tests and discovered a large mass in her chest. Days later, following a needle biopsy, Jen was diagnosed with Hodgkin's Lymphoma. Now in the care of Dr. James Essell with the OHC group at Jewish Hospital, she is in excellent hands. Jen started her first round of Chemo (ABVD)  in August of 2017; however after 7 rounds, PET scan results showed that not only was the treatment not working, but her tumor (aptly named Voldemort) had grown through the treatment. Unfortunately this puts Jen in a high risk group of Refractory Hodgkin's Lymphoma patients. Her next course of treatment was a newly released Immunotherpy drug called Brentuximab. After 2 treatments, PET scan results showed no sign of the tumor at all. Brentuximab unfortunately is not a final solution to Jen's cancer fight. It is only temporary to help shrink the size of the mass. In order to help put Jen in remission (hopefully a lifelong remission), she must undergo another, more intensive chemotherapy accompanied by a Stem Cell Transplant. This process is going to be long and arduous, but we all know Jen - she is quite the fighter.